Workflow
瑞丰高材(300243) - 2024 Q1 - 季度财报
RUIFENG CHEMRUIFENG CHEM(SZ:300243)2024-04-26 10:27

Financial Performance - The company's revenue for Q1 2024 was CNY 488,073,467.70, representing an increase of 18.81% compared to CNY 410,808,987.33 in the same period last year[6] - Net profit attributable to shareholders decreased by 44.71% to CNY 9,777,527.22 from CNY 17,683,765.50 year-on-year[6] - Basic and diluted earnings per share both dropped by 50% to CNY 0.04 from CNY 0.08 in the same period last year[6] - The net profit for Q1 2024 was CNY 9,775,638.33, a decrease of 44.8% from CNY 17,683,765.50 in Q1 2023[24] - The total operating revenue for Q1 2024 was CNY 488,073,467.70, representing an increase of 18.7% compared to CNY 410,808,987.33 in Q1 2023[23] - The total operating costs for Q1 2024 were CNY 473,856,904.42, up from CNY 391,848,756.89 in the same period last year, indicating a rise of 20.9%[23] Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -66,684,537.17, a decline of 60.78% compared to CNY -41,475,544.99 in the previous year[10] - The cash and cash equivalents decreased from 305,810,149.84 RMB to 244,476,768.70 RMB, a decline of approximately 20%[19] - The cash and cash equivalents at the end of the period were 130,734,220.72, compared to 79,895,741.24 at the end of the previous period, showing an increase in liquidity[28] - The company reported a total cash inflow from operating activities of 348,890,365.17, slightly up from 335,974,307.27 in the previous period[27] - The cash outflow from operating activities was 415,574,902.34, compared to 377,449,852.26 in the previous period, indicating increased operational expenses[27] - The total cash inflow from financing activities was 213,233,020.67, up from 139,300,000.00 in the previous period, primarily due to an increase in borrowings received[28] - Cash outflow from financing activities increased to 219,489,834.14 from 72,483,447.94, resulting in a net cash flow from financing activities of -6,256,813.47, down from 66,816,552.06[28] Assets and Liabilities - Total assets increased by 0.77% to CNY 2,190,373,502.45 from CNY 2,173,702,843.51 at the end of the previous year[6] - The total liabilities increased to CNY 1,039,735,954.62 in Q1 2024 from CNY 1,032,846,799.49 in Q1 2023[21] - The company's total assets as of the end of Q1 2024 amounted to CNY 2,190,373,502.45, compared to CNY 2,173,702,843.51 at the end of Q1 2023[21] Shareholder Information - The total number of common shareholders at the end of the reporting period is 16,099[12] - The largest shareholder, Zhou Shibin, holds 26.91% of shares, totaling 67,399,461 shares, with 21,760,000 shares pledged[12] - The company has no changes in the top 10 shareholders or the top 10 unrestricted shareholders due to securities lending[14] - The total number of restricted shares at the end of the period is 59,731,283 shares, with no new restrictions added[16] - The company has not reported any changes in the status of preferred shareholders or their holdings[14] Research and Development - Research and development expenses rose by 52.87% to CNY 1,795,056.56, reflecting increased investment in R&D and experimentation[9] - Research and development expenses for Q1 2024 were CNY 1,795,056.56, compared to CNY 1,174,232.85 in Q1 2023, reflecting a significant increase of 53.0%[24] - The company plans to continue focusing on the development of biodegradable polymer materials, with ongoing projects expected to enhance future profitability[6] Other Financial Metrics - The company experienced a 136.12% increase in other income to CNY 1,245,968.32, benefiting from VAT policy adjustments[9] - Long-term borrowings increased by 81.35% to CNY 200,552,000.00, indicating new bank loans taken during the reporting period[9] - The company reported a significant increase in interest expenses, which rose to CNY 9,370,355.77 from CNY 4,437,007.73 in the previous year[24] - The total equity attributable to the parent company was CNY 1,150,657,483.10, an increase from CNY 1,140,874,090.40 in Q1 2023[21] Capital Activities - The company issued 14,957,264 shares at a price of 7.02 RMB per share, raising a total of 105 million RMB, with shares listed on January 8, 2024[17] - The company is actively engaged in stock issuance to specific investors as part of its capital strategy[17] Inventory and Accounts Receivable - The company reported a significant increase in accounts receivable by 37.40% to CNY 396,980,820.82, attributed to concentrated year-end collections[9] - Accounts receivable increased from 288,922,023.41 RMB to 396,980,820.82 RMB, representing a growth of about 37.4%[19] - Inventory rose from 217,161,435.46 RMB to 247,508,237.45 RMB, an increase of approximately 14%[19] Investment Activities - The company invested 2,460,787.01 in fixed assets during the quarter, down from 28,690,044.52 in the previous period, indicating a reduction in capital expenditures[28] - The company’s cash flow from investment activities was -2,460,787.01, compared to -28,690,044.52 in the previous period, showing a decrease in investment losses[28] Market and Product Development - The company did not report any new product launches or significant market expansion strategies during the quarter[30]